Dexrazoxane

2 trials 2 recruiting VVarious

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

2 Sponsors

12 Countries

Phase III

Phase III: 2

Oversight events:

1 serious breach 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Diffuse large B-cell lymphoma 1

Sponsors using this IMP

Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting 1 Prinses Maxima Centrum voor Kinderoncologie B.V. 1

All trials

2 total

HOVON 170 DLBCL: ANTICIPATE: Prevention of ANThracycline-Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B-cell ly… Recruiting

2023-505377-32-00 Phase III 1 country Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon)
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Phase III 12 countries Prinses Maxima Centrum voor Kinderoncologie B.V.

Showing 1–2 of 2 trials

← All drugs A–Z